Here’s where we see the heat today:
Today we have huge movers in the tech space thanks to Oracle and RIM earnings, plus a drug breakthrough for Alkermes, JNJ’s latest take-out target, and more…
FROM UGLY TO HORRID: Arena gets a negative vote from the FDA on its key treatment, stock collapsing, even after having already done so
KEY EARNINGS: Research In Motion (RIMM) pulled an 'Oracle', beating expectations atferhours and surging
SHORT TARGET: Chinese travel company UTA is stabilizing after being slammed by fraud allegations from Bronte Capital
PHARMA CATALYST: Vivus (VVUS) is falling quite a bit, it might have something to do with bad news from the FDA
Business Insider Emails & Alerts
Site highlights each day to your inbox.